1 the short (s), as opposed to the long (l), allele of the 5-HT transporter linked polymorphism (5-HTTLPR) has been associated with neuroticism and depression.
The tendency for the majority of individuals in temperate latitudes to experience changes in behavior across the seasons has been termed seasonality. 4 Seasonality, as measured retrospectively by self-report, is a heritable trait 5 which varies in severity across individuals. Seasonality is present to a marked degree in patients with seasonal affective disorder (SAD), a condition of regularly recurring winter depressions alternating with non-depressed periods in spring and summer. 6 Although depression is also heritable, it is unclear whether SAD is inherited as a distinct entity or whether it affects individuals who are genetically susceptible to both seasonality and depression.
SAD has been hypothesized to result from disturbed brain serotonergic transmission 1 and patients with SAD have been shown to respond abnormally to drugs that act on serotonin (5-HT) receptors and favorably to antidepressants that block the 5-HTT. 1 Seasonal fluctuations in 5-HT hypothalamic concentration have been reported post-mortem in the general population, with lowest levels occurring in winter. 7 As the behaviors that vary with the seasons, including appetite, sleep, weight regulation and mood, are controlled in part by 5-HT pathways, seasonality may also be related to seasonal fluctuations in 5-HT function.
Given the importance of the 5-HTT in modulating 5-HT transmission 2 in the 5-HT synapse, variations in 5-HTT regulation may account for variations in seasonality in the general population and may be a risk factor for SAD. A polymorphism of the promoter of the 5-HTT gene [SCL6A4 localization on chromosome 17q12] has recently been described. 2 The polymorphism is an insertion or deletion of a 44-bp sequence located approximately 1 kb upstream from the coding sequence. The l and s variants of 5-HTTLPR appear to direct transcription with different efficiencies. 5-HTTLPR genotypes have been found to determine differences in 5-HTT m-RNA expression, in 5-HTT expression on cell surface membranes and in 5-HT uptake. 2 In all cases the l/l genotype yielded higher levels of 5-HTT function and expression than did the l/s or s/s genotypes, which did not differ significantly from each other. These data suggest that the s variant acts dominantly. Thus far the s allele has been linked to neuroticism, 2 depression 3 and autism. 8 We hypothesized that this less efficient allele would also be associated with SAD and with seasonality. This study tests this hypothesis in carefully evaluated SAD patients and normal controls who had low seasonality.
SAD patients were significantly less likely than controls to have the l/l genotype ( 2 = 7.13; P Ͻ 0.01; see Table 1 ) and the l allele ( 2 = 5.31; P Ͻ 0.02; see Table  2 ). The groups also differed significantly with regard to genotype ( 2 = 7.13; P Ͻ 0.03; see Table 3 ). Chi-square analysis revealed the relative risk for non-l/l genotype in SAD to be 1.38. When unipolar (n = 72) and bipolar (n = 25) were considered separately, unipolars were found to differ significantly from normal controls with respect to all three frequency distribution comparisons mentioned above ( 2 = 6.2; P Ͻ 0.02; 2 = 4.4; P Ͻ 0.04 = 6.2; P Ͻ 0.05 respectively). Comparisons between bipolars and controls did not reach statistical significance, probably because of insufficient statistical power as percentages of the l/l genotype and the s allele were virtually identical for unipolar and bipolar patients (28% vs 27.8% and 44.4% vs 46% respectively). There was also no association between genotype and gender or age of onset. Given the small number of subjects who were not Caucasian, it was not possible to run meaningful statistical analyses by race. Nevertheless, when only Caucasians were considered, the results remained unchanged.
When SAD patients were divided into l/l homozygotes vs l/s and s/s genotypes and compared on GSS scores, patients with the l/l genotype were found to have lower scores than patients with non-l/l genotypes (mean ± s.d. = 15.3 ± 2.8 and 17.1 ± 3.4 respectively; t = 2.5, P = 0.02, 2-tailed). The fraction of the GSS attributable to l/l vs non-l/l genotype was found to be 7.4%. There were no differences in GSS scores between s/s and l/s genotypes (t = 0.2; P = 0.8).
As hypothesized, the 5-HTTLPR s allele was more prevalent among SAD patients than among controls. This finding is consistent with other reports of this polymorphism being associated with psychopathology, specifically neuroticism, 2 major depressive disorder 3 and autism. 8 Although the meaningfulness of associations between polymorphisms and psychopathology has been questioned due to unreplicated results, 9 the association reported here is consistent with: (1) previous reports associating polymorphisms and psychopathology; and (2) the functional significance of the 5-HTTLPR variant for serotonergic transmission. Our observation that SAD patients who were homozygous for the l variant had lower levels of seasonality as compared to nonhomozygous l patients, provides additional evidence for a role of 5-HTTLPR in seasonality. The s allele may make a person more susceptible to increased sleep, appetite, and weight gain, and to lower mood, energy and level of socialization during the winter, a time when serotonergic transmission may be at its nadir. 7 We recognize the need to have this finding independently replicated in order to be fully confident of the validity of the association.
It is not clear whether the 5-HTTLPR is independently a risk factor for seasonality and for depression or for SAD as an entity. Comparisons between SAD and non-seasonal depressives would clarify this question. The frequency of the s allele in our SAD patients was comparable to that observed in patients with major depression studied elsewhere. 3 A study of the general population would clarify the degree to which the 5-HTTLPR contributes to seasonality per se. In this regard, it is worth noting that the frequency of the s allele in the low seasonality controls in this study was somewhat lower than that previously observed in controls not screened for seasonality (32.4% vs 40-45%). 3 Clearly the 5-HTTLPR does not explain all of the variance associated with seasonality since a sizable minority (27.8%) of SAD patients, who are by definition highly seasonal, are homozygous for the l variant. Nor does the s variant in itself necessarily lead to a high level of seasonality since approximately half (52.1%) of the controls screened specifically for very low levels of seasonality have the s variant.
Differences in the distributions of genotype between unipolar patients and controls were found but not between the bipolar patients and controls. Unipolar and bipolar patients did not, however, differ from each other in genotype distribution, nor have any unipolarbipolar differences in depressive symptoms or biological profiles of SAD patients ever been described. This raises a question as to the usefulness of dichotomizing SAD patients in this fashion.
Since individuals with high levels of seasonality, such as patients with SAD, may benefit from exposure to bright environmental light, 6 it is interesting to speculate that this treatment, which has been suggested to work by enhancing serotonergic transmission, 1 may override the effect of a genetic risk factor.
Methods

Subjects
SAD patients met diagnostic criteria of Rosenthal and colleagues 6 and controls were required to be free of any personal or family (first degree relative only) history of psychiatric disorder. All subjects were given the Seasonal Pattern Assessment Questionnaire (SPAQ), a selfadministered instrument which records a history of seasonal changes in several behaviors. 10 Six of these behaviors (sleeping, appetite, mood, energy level, weight and social behavior) are each evaluated on 0-4 point scales. The six scores are summed to create the global seasonality score (GSS), which can range from 0 to 24. The GSS has acceptable test-retest reliability and discriminates between different clinical groups, 10 as well as between normal individuals living at different latitudes. 11 The mean and range of GSS scores were 16.5 and 16 for patients and 2.0 and 6 for controls respectively.
In addition to the requirements outlined above, con-trols were required to have low levels of seasonality, as defined by a GSS score of 6 or less. The female to male ratio was 73:24 for patients and 43:28 for controls. Patients were diagnosed as unipolar (n = 72), bipolar I (n = 1) or bipolar II (n = 24) according to DSM-III-R criteria. Most subjects were Caucasian (86 of 97 patients and 70 of 71 controls). Of the non-Caucasian patients, eight were African-American, two were Hispanic and one was Asian; the single non-Caucasian control was Hispanic. All subjects were physically healthy and provided informed consent to participate in the study, which took place at the National Institute of Mental Health (NIMH). The study meets all ethical standards established at the NIMH.
Assay
Blood for DNA isolation and analysis was obtained from 97 SAD patients and 71 controls. Oligonucleotide primers flanking the 5-HTTLPR were used to detect the two different 5-HTTLPR alleles by means of the polymerase chain reaction, as described elsewhere.
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Statistical analyses
Since the short variant of the 5-HTTLPR is hypothesized to be dominant in its action on 5-HTT function and behavior, 2 we performed a primary analysis by comparing l/l homozygotes with the combined group of s/s homozygotes and heterozygotes across both groups using 2 analysis. We then also performed 2 analyses on allele frequency distributions across all three genotypes and determined a relative risk of 1.38 for non-l/l genotypes in SAD. Preliminary to all 2 analyses, we tested for Hardy-Weinberg equilibrium and found that the genotypes were distributed according to the Hardy-Weinberg equilibrium ( 2 for controls = 0.7 and for patients = 0.64). In order to determine whether the s and l variants are associated with seasonality and not just clinical status, we compared the GSS of the different genotypes within the SAD group by means of t-tests. We predicted that the l/l homozygotes would have lower GSS scores than the l/s and s/s combined, but that these two groups would not differ from each other. We did not expect to find any differences within controls because of their low scores and the small variance in their GSS scores, as would be expected from the inclusion criteria. The different genotypes were also compared with regard to gender, affective disorder subtype and age of onset of SAD. Given possible ethnic differences in genotypes, all statistical analyses were performed on both the entire group (97 patients and 71 controls) and on the Caucasian subjects alone (86 patients and 70 controls).
